These findings highlight the dual observations with Retatrutide in subjects with type 2 diabetes, combining pronounced glucose-lowering effects with notable anti-obesity propertiesparticularly relevant given the strong association between obesity, insulin resistance, and impaired glycemic control
However, a retrospective cohort study of electronic health records involving 240,618 patients with overweight or obesity prescribed semaglutide or non-GLP-1 receptor agonist antiobesity medications, and 1,589,855 patients with type 2 diabetes prescribed semaglutide or other hypoglycaemic agents, found a lower risk of suicidal ideation in patients prescribed semaglutide regardless of prior psychiatric history
Participants should have tried and failed to lose weight through dieting, may have knee pain due to osteoarthritis for over 12 weeks, and/or moderate-to-severe obstructive sleep apnea but not on PAP therapy
Adems, algunos estudios estn evaluando la posibilidad de usar la retatrutida para disminuir el riesgo y la progresin de algunos tipos de cncer, como el de pncreas y el de pulmn
Arterburn DE, Johnson E, Coleman KJ, et al
Connect With Us: Check out our Google reviews: Read What Our Customers Are Saying
